Examining the effectiveness of two different doses of dexamethasone when used as an additive to upper limb nerve block
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: S698- Other specified injuries of wrist,hand and finger(s)Health Condition 2: S599- Unspecified injury of elbow and forearmHealth Condition 3: S499- Unspecified injury of shoulder andupper arm
- Registration Number
- CTRI/2024/03/064718
- Lead Sponsor
- Divya Prabhash
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients undergoing upper limb surgeries under supraclavicular brachial plexus block.
Exclusion Criteria
1. Patient refusal
2. Neurological deficits involving brachial plexus
3. Patients with diabetes mellitus, hepatic or renal failure
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine onset of sensory blockade with two different doses of dexamethasone as adjuvant to block.Timepoint: In minutes
- Secondary Outcome Measures
Name Time Method Onset and Duration of motor blockadeTimepoint: In minutes;Side Effects / ComplicationsTimepoint: (If any);To determine duration of sensory blockade with two different doses of dexamethasone as adjuvant to block.Timepoint: In minutes
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain dexamethasone's adjuvant effects in brachial plexus blocks?
How does dexamethasone dose-response compare to standard-of-care analgesics in upper limb nerve blocks?
Which biomarkers correlate with enhanced analgesia from dexamethasone in brachial plexus blocks?
What adverse events are associated with dexamethasone as an adjuvant in regional anesthesia?
Are there combination therapies with dexamethasone for improved postoperative outcomes in upper limb surgery?